Wu J, Cheng B, Song Y, Cheng J, et al. Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer. Cancer Res 2025 Oct 9. doi: 10.1158/0008-5472.CAN-25-0024.
PMID: 41066596